SCHEMBL8869818

SCHEMBL8869818

CCOC(=O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)cc2)cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.51
TSHR P16473 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
BLM P54132 2/20 0.51
CYP3A4 P08684 1/20 0.51
HTR1A P08908 1/20 0.51
MAPT P10636 1/20 0.51
CYP2C9 P11712 1/20 0.51
NFKB1 P19838 1/20 0.51
CNR1 P21554 1/20 0.51
CYP2C19 P33261 1/20 0.51
ADRA1A P35348 1/20 0.51
KMT2A Q03164 1/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA9 Q16790 1/20 0.45
HTT P42858 1/20 0.44
P4HTM Q9NXG6 2/20 0.44
ALDH1A1 P00352 2/20 0.43
THRB P10828 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868031 0.93 LMNA (0.47) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8868631 0.92 LMNA (0.51) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8868039 0.89 LMNA (0.48) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8868742 0.88 LMNA (0.48) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL9140466 0.88 LMNA (0.51) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8870465 0.87 LMNA (0.52) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8867992 0.87 LMNA (0.51) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8873747 0.86 LMNA (0.44) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8874675 0.86 L3MBTL1 (0.43) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8869950 0.85 LMNA (0.54) LMNATSHRSMN1; SMN2BLMCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed